Home › Products › Gastroenterology › Zurig 80mg Tablet
Zurig 80mg Tablet
Salt Composition: FEBUXOSTAT
- Manufacturer: ZYDUS CADILA
- Pack Size: 30 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 80MG
- Prescription Required
- Storage: Store Zurig 80mg tablet in the original package at room temperature (15°C to 30°C). Keep it out of reach from children.
₹457.00₹570.84
Inclusive of all taxes
Product Introduction
Zurig 80mg Tablet contains the active ingredient Febuxostat and belongs to the class of medicines known as xanthine oxidase inhibitors. It is primarily prescribed for the treatment of gout, a type of arthritis caused by the accumulation of excess uric acid in the body. High uric acid levels can lead to the formation of crystals in the joints, resulting in severe pain, swelling, tenderness, redness, and stiffness, most commonly affecting the big toe, but also the heels, knees, wrists, fingers, and ears. In addition to gout management, Zurig 80mg Tablet is used to reduce uric acid levels in patients receiving chemotherapy for blood cancers, helping to lower the risk of complications associated with tumour breakdown.
The Zurig 80mg Tablet composition includes Febuxostat as its active ingredient, which works by blocking the enzyme xanthine oxidase, thereby reducing the production of uric acid in the body. When comparing Zurig 80mg vs Febuxostat, it is important to note that Zurig 80mg is itself a Febuxostat-based medicine and offers the same therapeutic benefits as other brands containing the same active ingredient. If this brand is unavailable, your doctor may recommend a suitable Zurig 80mg substitute with an equivalent formulation and effectiveness.
The Zurig 80mg Tablet dosage is generally one tablet once daily, although the exact dose and duration will depend on your medical condition and your doctor's advice. Patients often search for how to take Zurig 80mg Tablet, and it is recommended to swallow the tablet whole with a glass of water, with or without food, exactly as prescribed. According to Zurig 80mg reviews, many patients experience fewer gout attacks and improved symptom control when the medicine is taken regularly under medical supervision. Maintaining adequate hydration and following a low-purine diet can further enhance treatment outcomes and support long-term uric acid control.
Always use this medicine as directed by your doctor and avoid discontinuing it without medical advice, even if your symptoms improve.
Uses
Zurig tablet uses are Treatment of Gout Treatment of Chemotherapy for blood cancer
How it works
It works by inhibiting the enzyme called xanthine oxidase inhibitors, which are responsible for the production of uric acid in the body. By inhibiting this enzyme, this drug reduces the production of uric acid, which can help prevent gout attacks and the formation of uric acid crystals in the joints and other tissues.
How to Use
Your doctor will decide the dose and duration of Zurig 80mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet at the same time every day, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Zurig 80mg side effects are Common Diarrhea Headache Rash Nausea Increase in gout symptoms Localised swelling due to retention of fluids in tissues Abnormal liver function Kidney problems
References
- Accord healthcare limited, Electronic medicines compendium (EMC), [Revised on July 2020] [ Accessed on 12th July 2021], https://www.medicines.org.uk/emc/files/pil.10184.pdf
- Takeda Pharmaceuticals America, Inc, US Food and Drug Administration, [Revised on March 2013] [ Accessed on 12th July 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021856s011lbl.pdf
- Takai M;Yamauchi T;Ookura M;Matsuda Y;Tai K;Kishi S;Yoshida A;Iwasaki H;Nakamura T;Ueda T; Febuxostat for management of tumour lysis syndrome including its effects on levels of purine metabolites in patients with haematological malignancies - a single institution's, pharmacokinetic and pilot prospective study, Anticancer research. U.S. National Library of Medicine. Available at: https://pubmed.ncbi.nlm.nih.gov/25503162/ (Accessed on March 25, 2023).
- Takai, M. et al. (2014) Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome, Oncology letters. U.S. National Library of Medicine. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156226/ (Accessed on March 25, 2023).
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout, 12th edition, 2011, 1499.
- KD Tripathi, Essentials of Medical Pharmacology, Antirheumatoid and antigout drugs, 7th edition, 2013, 217.
Safety Advice
Pregnancy: unsafe Zurig 80mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Lungs: Consult your doctor It is not known whether Zurig 80mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: Consult your doctor It is not known if Zurig 80mg tablet passes into your breast milk or if it will affect your baby. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.